Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinglei Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Gu

    Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    3 shared publications
  • Chuan Chen

    Department of Otorhinolaryngology Head and Neck Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

    2 shared publications
  • Chuan Liu

    Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    2 shared publications
  • Jian Wang

    Department of Otolaryngology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    2 shared publications
  • Chuan Liu

    Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    1 shared publication
  • Jian Wang

    Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

    1 shared publication

Latest Publications

  • Open Access

    From Glycan Biology to Drug Candidates: An Integrated Sialylation Niche Index and AI-Guided Therapeutic Framework for Head and Neck Squamous Cell Carcinoma

    by Wei Gu, Chuan Liu, Jinglei Li, Jian Wang

    Background: Head and neck squamous cell carcinoma (HNSCC) responds poorly (n = 501) were analysed with a 1204-gene sialylation compendium. The Sialylation Niche Index (SNI) was built in TCGA-HNSC from 117 machine-learning algorithm combinations (nominally 101), with survival-based feature selection and model fitting confined to the training set; model selection used TCGA-HNSC and the external model-selection cohort GSE42743 (n = 74 with overall survival), and the three independent test cohorts were scored without re-fitting (E-MTAB-8588, n = 83; GSE65858, n = 270; and GSE41613, n = 97). Key model genes were characterised by single-cell RNA sequencing (168,742 cells), spatial transcriptomics, and AI-guided screening of 249,455 compounds. Results: Thirty-one prognostic sialylation-associated DEGs defined an immunosuppressive subtype (C1) and an immune-active subtype (C2) with divergent survival. The SNI achieved a C-index of 0.88 in TCGA-HNSC, 0.68 in GSE42743, and 0.58–0.62 in the three independent test cohorts and remained independently prognostic after adjustment for age and other clinicopathological variables in multivariable analysis. SHAP analysis identified HSPH1 (risk-associated) and ST6GALNAC1 (protective) as principal contributors with opposing microenvironmental associations. Conclusions: Sialylation constitutes a distinct immunosuppressive axis in HNSCC, complementary to PD-1 blockade. The SNI provides a biologically anchored prognostic framework whose cross-platform transfer requires recalibration; putative candidate compounds require experimental validation.

  • Open Access

    Dynamic CD4+ T Cell Genetics Identifies Candidate Therapeutic Targets for Allergic Rhinitis: Mendelian Randomization with Exploratory Single-Cell Contextualization

    by Wei Gu, Jinglei Li, Chuan Liu, Chuan Chen, Jian Wang

    Background: Allergic rhinitis is common and clinically heterogeneous, but the genes whose genetically regulated immune-state expression influences susceptibility remain incompletely resolved. Methods: We integrated dynamic CD4+ T cell eQTL data (46 activation-state profiles) with allergic rhinitis GWAS summary statistics, applying transcriptome-wide Mendelian randomization (MR), colocalization, SMR/HEIDI, metabolite screening, paired single-cell RNA-seq and TCR analysis, and computational follow-up. Colocalization support was prespecified as conditional ratio PP.H4/(PP.H3 + PP.H4) > 0.7; HEIDI at p > 0.05. Results: After MHC-region exclusion, 50,654 gene-profile pairs were tested and 129 MR-significant genes were identified. Colocalization supported 418 pairs (111 genes); 70 genes passed both SMR and HEIDI; and cross-database comparison yielded a nine-gene overlap set. In GSE200107, baseline good-versus-poor responder differences were larger than treatment-induced transcriptional change; patient-level reanalysis found no pair surviving multiple-testing correction (n = 4 vs. 3); these findings are hypothesis-generating. Paired TCR analysis suggested greater clonotype renewal in good responders (descriptive). Structure-guided screening prioritized unvalidated binder candidates for SLC25A46 and TLR1 (TLR1 TIR docking −5.86 kcal/mol; MD RMSD 0.20 nm). Conclusions: An exploratory metabolite screen yielded nominally significant indirect-effect signals, but the candidate metabolite did not colocalize with the disease locus. This framework prioritizes candidate therapeutic targets for allergic rhinitis.

  • Open Access

    Imaging Characteristics and Postoperative Outcomes of Head and Neck Unicentric Castleman Disease: A 20-Year Institutional Experience

    by Chuan Liu, Jing-Lei Li, Chuan Chen, Wei Gu, Jian Wang

    Purpose: Head and neck unicentric Castleman disease (HN-UCD) often lacks specific clinical and laboratory markers, leading to frequent preoperative misdiagnoses. While surgical resection typically offers a favorable prognosis, the management of atypical postoperative outcomes, such as new regional lymphadenopathy or persistent systemic symptoms, remains poorly defined. This study aimed to identify the characteristic imaging features of HN-UCD and explore effective management strategies for these atypical postoperative scenarios. Methods: A retrospective analysis was conducted on 24 patients diagnosed with HN-UCD at the Peking Union Medical College Hospital over the past 20 years. The preoperative imaging characteristics and postoperative clinical outcomes were systematically evaluated. Results: Imaging confirmed significant hypervascularity as a hallmark of HN-UCD: 94.4% (17/18) of lesions exhibited abundant and disordered blood flow signals on ultrasound, and 71.4% (10/14) of lesions presented with prominent feeding vessels on CT. Postoperatively, 87.5% (21/24) of the patients achieved complete remission within the surgical field. For the two patients exhibiting atypical outcomes (new regional lymphadenopathy and persistent fever), a strategy of rigorous follow-up was adopted after multidisciplinary exclusion of malignancy and infection; both patients remained clinically stable. Conclusion: Prominent feeding vessels and marked hypervascularity are characteristic preoperative imaging markers for HN-UCD. For patients with atypical postoperative outcomes, a management protocol based on multidisciplinary evaluation and close clinical observation is recommended.